Czech Republic vs Peru: Dealing with construction permits: Quality control after construction
Czech Republic
3 DB16-20 methodology
in 2019
Peru
3 DB16-20 methodology
in 2019
Czech Republic rank
1st
Peru rank
1st
Dealing with construction permits: Quality control after construction over time
- Czech Republic
- Peru
How they compare
Czech Republic currently reports 3 DB16-20 methodology against 3 DB16-20 methodology in Peru, a difference of 0 DB16-20 methodology.
Across all 6 years both countries report, Peru has been ahead every year.
Czech Republic ranks 1st and Peru ranks 1st of 185 countries.
Frequently asked questions
- Which has higher dealing with construction permits: quality control after construction, Czech Republic or Peru?
- Czech Republic, at 3 DB16-20 methodology against 3 DB16-20 methodology in Peru as of 2019.
- What is the difference in dealing with construction permits: quality control after construction between Czech Republic and Peru?
- 0 DB16-20 methodology, with Czech Republic ahead.
- How many years of comparable data are there for Czech Republic and Peru?
- 6 years are reported by both, from 2014 to 2019.
- How do Czech Republic and Peru rank globally for dealing with construction permits: quality control after construction?
- Czech Republic ranks 1st and Peru ranks 1st of 185 countries.
- Where does this data come from?
- The World Bank, published as Dealing with construction permits: Quality control after construction index (0-3) (DB16-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The quality control after construction index evaluates quality control after the construction process. It has two components: (i) whether a final inspection is mandated by law to verify that the building was built in accordance with the approved plans and existing building regulations; and (ii) whether the final inspection is implemented in practice. The index is computed based on the methodology in the DB16-20 studies.